Shengzhou Wu

929 total citations
39 papers, 703 citations indexed

About

Shengzhou Wu is a scholar working on Molecular Biology, Biochemistry and Physiology. According to data from OpenAlex, Shengzhou Wu has authored 39 papers receiving a total of 703 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 17 papers in Biochemistry and 9 papers in Physiology. Recurrent topics in Shengzhou Wu's work include Amino Acid Enzymes and Metabolism (17 papers), Epigenetics and DNA Methylation (11 papers) and Alzheimer's disease research and treatments (8 papers). Shengzhou Wu is often cited by papers focused on Amino Acid Enzymes and Metabolism (17 papers), Epigenetics and DNA Methylation (11 papers) and Alzheimer's disease research and treatments (8 papers). Shengzhou Wu collaborates with scholars based in China, United States and Thailand. Shengzhou Wu's co-authors include Steven W. Barger, Anthony S. Basile, Angela M. Bodles, W. Sue T. Griffin, He Zhang, Haiyan Jiang, Jingjing Cai, Jia Qu, Lin Sun and Terry J. Sims and has published in prestigious journals such as PLoS ONE, Brain Research and The FASEB Journal.

In The Last Decade

Shengzhou Wu

35 papers receiving 700 citations

Peers

Shengzhou Wu
Barbara A. Mysona United States
Jennifer Duplantier United States
D. Z. Gerhart United States
Macy E. Zardeneta United States
Gary P. H. Ho United States
Brian S. Rogers United States
Timothy P. Kegelman United States
Barbara A. Mysona United States
Shengzhou Wu
Citations per year, relative to Shengzhou Wu Shengzhou Wu (= 1×) peers Barbara A. Mysona

Countries citing papers authored by Shengzhou Wu

Since Specialization
Citations

This map shows the geographic impact of Shengzhou Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shengzhou Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shengzhou Wu more than expected).

Fields of papers citing papers by Shengzhou Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shengzhou Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shengzhou Wu. The network helps show where Shengzhou Wu may publish in the future.

Co-authorship network of co-authors of Shengzhou Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Shengzhou Wu. A scholar is included among the top collaborators of Shengzhou Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shengzhou Wu. Shengzhou Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Yan, Yang Zhao, Haiyan Jiang, et al.. (2025). Age- and Sex-Specific Regulation of Serine Racemase in the Retina of an Alzheimer's Disease Mouse. Investigative Ophthalmology & Visual Science. 66(1). 36–36. 1 indexed citations
2.
Shen, Yujing, Shengzhou Wu, Junwu Wang, et al.. (2025). SIRT1 Attenuates Neuropathic Pain via CDK5-Kalirin-7 Signaling Pathway in Type 2 Diabetic Rats. Molecular Neurobiology. 62(8). 9670–9685.
3.
Liu, Yu, Haiyan Jiang, Gong Li, et al.. (2024). Effects of Topic Delivery of an Inhibitor of Serine Racemase on Laser-Induced Choroidal Vasculopathy. Translational Vision Science & Technology. 13(8). 24–24. 1 indexed citations
4.
Cai, Jingjing, et al.. (2024). Regulation of LAMTOR1 by oxidative stress in retinal pigment epithelium: Implications for age-related macular degeneration pathogenesis. Experimental Eye Research. 249. 110129–110129. 2 indexed citations
5.
Liu, Yimei, et al.. (2021). Repurposing bortezomib for choroidal neovascularization treatment via antagonizing VEGF-A and PDGF-D mediated signaling. Experimental Eye Research. 204. 108446–108446. 9 indexed citations
6.
Wang, Yan, et al.. (2020). Dicer1 promotes Aβ clearance via blocking B2 RNA-mediated repression of apolipoprotein E. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1867(2). 166038–166038. 2 indexed citations
7.
Jiang, Haiyan, He Zhang, Xue Jiang, & Shengzhou Wu. (2020). Overexpression of d-amino acid oxidase prevents retinal neurovascular pathologies in diabetic rats. Diabetologia. 64(3). 693–706. 20 indexed citations
8.
Wu, Mengjuan, Yimei Liu, He Zhang, et al.. (2019). Intravenous injection of l-aspartic acid β-hydroxamate attenuates choroidal neovascularization via anti-VEGF and anti-inflammation. Experimental Eye Research. 182. 93–100. 10 indexed citations
9.
Jiang, Haiyan, Juan Song, Yanqi Li, et al.. (2018). Loss-of-function mutation of serine racemase attenuates retinal ganglion cell loss in diabetic mice. Experimental Eye Research. 175. 90–97. 13 indexed citations
10.
Cai, Jingjing, He Zhang, Yun Feng Zhang, Zhonglou Zhou, & Shengzhou Wu. (2018). MicroRNA-29 enhances autophagy and cleanses exogenous mutant αB-crystallin in retinal pigment epithelial cells. Experimental Cell Research. 374(1). 231–248. 34 indexed citations
11.
Zhang, He, Liping Song, Yuhua Chang, et al.. (2017). Potential deficit from decreased cerebellar granule cell migration in serine racemase-deficient mice is reversed by increased expression of GluN2B and elevated levels of NMDAR agonists. Molecular and Cellular Neuroscience. 85. 119–126. 7 indexed citations
13.
Cai, Jingjing, Bing Lin, Xianwei Wang, et al.. (2014). Roles of NFκB-miR-29s-MMP-2 circuitry in experimental choroidal neovascularization. Journal of Neuroinflammation. 11(1). 88–88. 31 indexed citations
14.
Gao, Yan, et al.. (2012). Reliability of the Boston bowel preparation scale. Zhonghua xiaohua neijing zazhi. 29(2). 78–80. 1 indexed citations
15.
Wu, Shengzhou, et al.. (2009). Cellular calcium deficiency plays a role in neuronal death caused by proteasome inhibitors. Journal of Neurochemistry. 109(5). 1225–1236. 12 indexed citations
16.
Wu, Shengzhou, Anthony S. Basile, & Steven W. Barger. (2007). Induction of Serine Racemase Expression and D-Serine Release from Microglia by Secreted Amyloid Precursor Protein (sAPP). Current Alzheimer Research. 4(3). 243–251. 39 indexed citations
17.
Wu, Shengzhou, Shujun Jiang, Terry J. Sims, & Steven W. Barger. (2005). Schwann cells exhibit excitotoxicity consistent with release of NMDA receptor agonists. Journal of Neuroscience Research. 79(5). 638–643. 22 indexed citations
18.
Wu, Shengzhou, Steven W. Barger, & Terry J. Sims. (2004). Schwann cell and epineural fibroblast expression of serine racemase. Brain Research. 1020(1-2). 161–166. 17 indexed citations
19.
Wu, Shengzhou & Steven W. Barger. (2004). Induction of Serine Racemase by Inflammatory Stimuli Is Dependent on AP‐1. Annals of the New York Academy of Sciences. 1035(1). 133–146. 67 indexed citations
20.
Wu, Shengzhou, et al.. (2004). Induction of serine racemase expression and D-serine release from microglia by amyloid beta-peptide.. Journal of Neuroinflammation. 1(1). 2–2. 165 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026